×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

Early Cost-Effectiveness Modeling With PK/PD Data

August 22, 2017

Expert in outcomes and evidence, Richard Willke, talks through early-stage economic modeling using pharmacokinetic/ pharmacodynamic (PK/PD) data sets; detailing what has been achieved so far and what further potential it holds.

Previous Flipbook
Today's Gold Standard -Product Approval Demands Real-World Evidence
Today's Gold Standard -Product Approval Demands Real-World Evidence

Next Flipbook
Market Access Data: Fuel for Successful Product Launches
Market Access Data: Fuel for Successful Product Launches

Learn more about commercialization and market access here!